Transcept Pharmaceuticals Inc. (TSPT) Wednesday reported first-quarter net loss of $10.5 million or $0.56 per share, compared with net loss of $5 million or $0.37 per share last year.
On average, six analysts polled by Thomson Reuters estimated a loss of $0.36 per share for the quarter. Analysts' estimates typically exclude special items.
The company reported royalty revenues of $0.5 million for the quarterly, reflecting Intermezzo net sales generated by Purdue.
This was offset by $6.3 million of contribution by Transcept to an Intermezzo direct-to-consumer advertising campaign led by Purdue, thereby leading to negative revenues of $5.8 million. Meanwhile, the company did not generate any revenues in the prior-year quarter.
Analysts estimated negative revenues of $1.5 million for the quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.